Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud D Roth

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 30, 2003
European experience of docetaxel and cisplatin in advanced gastric cancerArnaud D Roth
Critical Reviews in Oncology/Hematology|April 4, 2003
Curative treatment of gastric cancer: towards a multidisciplinary approach?Arnaud D Roth
Case Reports in Oncology|December 28, 2017
Long-Term Survival with Regorafenib in <i>KRAS</i>-Mutated Metastatic Rectal CancerMarie-Laure Amram, Xavier Montet, Arnaud D Roth
Journal of the National Cancer Institute|March 12, 2015
ResponseMauro Delorenzi, Sabine Tejpar, Arnaud D Roth, et al.
BMC Cancer|June 28, 2011
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancersMarta Bonet Beltrán, Arnaud D Roth, Gilles Mentha, et al.
Journal of the National Cancer Institute|May 21, 2011
Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzleSabine Tejpar, Zacharenia Saridaki, Mauro Delorenzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Thomas Zilli, Ulrike Schick, Mahmut Ozsahin, et al.
Revue Medicale Suisse|September 5, 2009
[Gastric neoplasm, multidisciplinary management]P ierre Bohanes, Arnaud D Roth, O Huber, et al.
BMC Cancer|October 1, 2013
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancerVlad Popovici, Eva Budinska, Fred T Bosman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trialViviane Hess, Marc Salzberg, Markus Borner, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 30, 2003
European experience of docetaxel and cisplatin in advanced gastric cancerArnaud D Roth
Critical Reviews in Oncology/Hematology|April 4, 2003
Curative treatment of gastric cancer: towards a multidisciplinary approach?Arnaud D Roth
Case Reports in Oncology|December 28, 2017
Long-Term Survival with Regorafenib in <i>KRAS</i>-Mutated Metastatic Rectal CancerMarie-Laure Amram, Xavier Montet, Arnaud D Roth
Journal of the National Cancer Institute|March 12, 2015
ResponseMauro Delorenzi, Sabine Tejpar, Arnaud D Roth, et al.
BMC Cancer|June 28, 2011
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancersMarta Bonet Beltrán, Arnaud D Roth, Gilles Mentha, et al.
Journal of the National Cancer Institute|May 21, 2011
Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzleSabine Tejpar, Zacharenia Saridaki, Mauro Delorenzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Thomas Zilli, Ulrike Schick, Mahmut Ozsahin, et al.
Revue Medicale Suisse|September 5, 2009
[Gastric neoplasm, multidisciplinary management]P ierre Bohanes, Arnaud D Roth, O Huber, et al.
BMC Cancer|October 1, 2013
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancerVlad Popovici, Eva Budinska, Fred T Bosman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trialViviane Hess, Marc Salzberg, Markus Borner, et al.
Pageof 4